Diatrizoate Meglumine and Diatrizoate Sodium is a Oral; Rectal Solution in the Human Prescription Drug category. It is labeled and distributed by Guardian Drug Company. The primary component is Diatrizoate Meglumine; Diatrizoate Sodium.
| Product ID | 53041-690_9cfdb214-1075-4449-9a01-f04cf5d0edfe |
| NDC | 53041-690 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Diatrizoate Meglumine and Diatrizoate Sodium |
| Generic Name | Diatrizoate Meglumine And Diatrizoate Sodium |
| Dosage Form | Solution |
| Route of Administration | ORAL; RECTAL |
| Marketing Start Date | 2019-12-18 |
| Marketing Category | ANDA / |
| Application Number | ANDA214201 |
| Labeler Name | Guardian Drug Company |
| Substance Name | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM |
| Active Ingredient Strength | 660 mg/mL; mg/mL |
| Pharm Classes | Radiographic Contrast Agent [EPC], Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA], X-Ray Contrast Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2019-12-18 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 53041-688 | Diatrizoate Meglumine and Diatrizoate Sodium | Diatrizoate Meglumine and Diatrizoate Sodium |
| 53041-690 | Diatrizoate Meglumine and Diatrizoate Sodium | Diatrizoate Meglumine and Diatrizoate Sodium |
| 0270-0445 | Gastrografin | diatrizoate meglumine and diatrizoate sodium |
| 0019-4816 | MD GASTROVIEW | diatrizoate meglumine and diatrizoate sodium |